HOME >> MEDICINE >> NEWS
Cancer drug can extend survival in patients with deadly brain tumors

DURHAM, N.C. -- Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

The study marks the first time that Avastin has been tested against brain tumors, the researchers said. The drug, whose chemical name is bevacizumab, currently is used to treat lung and colorectal cancers.

The researchers tested the effectiveness of Avastin in conjunction with a standard chemotherapy agent in patients with recurrent cancerous brain tumors called gliomas. They found that the two drugs together halted tumor growth up to twice as long as comparative therapies. Though gliomas remain incurable in nearly all cases, the combined drug therapy may buy precious time and preserve physical and mental function longer for patients facing this grim diagnosis, the researchers said.

"These results are exciting because of the possible implications for a patient population that currently has the poorest possible prognosis going into treatment, those with malignant brain tumors that have recurred after initial treatment," said James Vredenburgh, M.D., a brain cancer specialist at Dukes Preston Robert Tisch Brain Tumor Center and lead researcher on the study.

The findings will appear in the Feb. 20, 2007, issue of the journal Clinical Cancer Research. The study was funded by the National Institutes of Health, the Preston Robert Tisch Brain Tumor Research Fund, the Bryan Cless Research Fund and Genentech, the maker of Avastin.

Duke currently is participating in a large, multi-institutional study of Avastin to corroborate the results of this initial study, Vredenburgh said.

Kate Carr, president and chief executive officer of Accelerate Brain Cancer Cure, a not-for-profit organization that supports research to hasten a cure for brain cancer, said, "The re
'"/>

Contact: Lauren Shaftel
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
20-Feb-2007


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer drug can extend survival patients with deadly brain tumors

(Date:11/28/2014)... November 28, 2014 ARTAS robotic hair ... the first time. PAI Medical Group hair transplant surgeons ... performing a robotic hair transplant procedure in the Brentwood ... , The first in Tennessee and one of only ... now offers ARTAS robotic hair transplantation. Patients benefit from ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 ... worldwide dental market along with the definite portrayal ... point by point depiction of various variables driving ... patterns and difficulties blocking the development of the ... http://www.marketreportsonline.com/376605.html . , According to the report ...
(Date:11/27/2014)... 2014 As everyone knows, Cyber Monday is ... its customers, Tidebuy is now providing many big ... products at only 15% of the current prices. The discount ... huge savings and free shipping (for orders above $88) from ... network technology, more and more people are willing to shop ...
(Date:11/27/2014)... 2014 This is a professional and ... Bronchoscopes industry with a focus on the Chinese market. ... of the Bronchoscopes manufacturers and is a valuable source ... in the industry. , Firstly, the report provides a ... and manufacturing technology. Then, the report explores the international ...
(Date:11/27/2014)... November 27, 2014 Absolute PhysioCare ... recently announced that its personalized treatment plans, highly ... can help victims of sports injuries reach pre-injury ... or patellofemoral pain syndrome, Absolute Physio has the ... jumper’s knee, ACL tears, meniscal injuries, groin strain ...
Breaking Medicine News(10 mins):Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Global Dental Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Dental Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2
(Date:11/27/2014)... Nov. 27, 2014  Javon Bea Mercy Health ... faculty and staff at Janesville Craig High School and ... Mercy Health System physicians and Janesville ... Departments and the Janesville School ... Program, dedicated to providing schools and other organizations with ...
(Date:11/26/2014)... PLEASANTON, Calif. , Nov. 26, 2014  Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in two upcoming investor conferences. On ... 26 th Annual Piper Jaffray Healthcare Conference.  ... will provide an update on the company beginning at ...
(Date:11/26/2014)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... Products®," today announced the closing of Perrigo,s previously announced ... ordinary shares at a public offering price of $152.00 ... to purchase up to an additional 888,157 ordinary shares ... as representatives of the several underwriters. ...
Breaking Medicine Technology:Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4
Cached News: